DPT III Exam 2 (tran)

0.0(0)
studied byStudied by 0 people
0.0(0)
full-widthCall with Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/85

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No study sessions yet.

86 Terms

1
New cards

which types of SSTIs are typically associated with purulence?

folliculitis, furuncles

carbuncles

± impetigo

abscess

± diabetic foot infection

± human or animal bites

2
New cards

which types of SSTIs are not typically associated with purulence?

erysipelas

cellulitis

necrotizing fasciitis

3
New cards

which two gram-positive organisms are typically associated with SSTIs?

Streptococcus spp. and Staphylococcus spp.

4
New cards

which gram-positive organism is typically associated with purulence?

Staphylococcus spp.

5
New cards

an infection with which organism classically presents as "streaking, nonpurulent cellulitis"?

Streptococcus spp

6
New cards

mild SSTI

description:

treatment:

P: I&D

NP: oral abx

7
New cards

moderate SSTI

description:

systemic signs of infection

treatment:

P: I&D + oral abx

NP: IV abx

8
New cards

severe SSTI

description:

P: failed I&D + oral abx OR systemic signs of infection OR immunocompromised patients

NP: failed oral abx OR systemic signs of infection OR immunocompromised patients OR clinical signs of deeper infection OR evidence of organ dysfunction

treatment:

P: I&D + IV abx

NP: IV abx (broad-spectrum)

9
New cards

mild diabetic food infection

description:

local infection (involves only the skin and subcutaneous tissue) AND no systemic signs; if erythema present must be > 0.5 cm to ≤ 2 cm around the ulcer

treatment:

oral abx

probable pathogens: Staphylococcus aureus, Streptococcus spp.

10
New cards

moderate diabetic food infection

description:

no systemic signs AND local infection + erythema > 2 cm OR involvement of deeper structures

treatment:

oral OR IV abx

probable pathogens: polymicrobial**

11
New cards

severe diabetic food infection

description:

local infection AND ≥ 2 signs of SIRS*

treatment:

oral OR IV abx

probable pathogens: polymicrobial**

12
New cards

what are the MRSA risk factors for SSTIs?

-purulence

-history of previous MRSA infection

-high local prevalence of MRSA

-use of antibiotics in last month

-hospitalization in the past year

-history or previous MRSA colonization

-MRSA nares swab

13
New cards

what are the Psuedomonas risk factors for SSTIs?

-warm climate

-frequent exposure of foot to water

-high prevalence of Pseudomonas

-severe infection

14
New cards

true or false: Cephalosporins should always be avoided in the setting of a penicillin allergy.

false

15
New cards

in assessing susceptibility patterns in an antibiogram, what percentage cutoff would warrant AVOIDANCE of

that antibiotic for empiric coverage?

80

16
New cards

are there renal dose adjustments for dicloxacillin, nafcillin, and oxacillin?

no

17
New cards

what do penicillin G and penicillin VK have a DDI against?

probenecid

18
New cards

should you use higher or lower doses if piperacillin-tazobactam for more severe infections?

higher

19
New cards

does piperacillin-tazobactam have Pseudomonas coverage?

yes

20
New cards

cefepime adverse effect

neurotoxicity

21
New cards

does ceftriaxone need renal dose adjustments?

no

22
New cards

tedizolid adverse effect

myelosuppression, peripheral neuropathy, serotonin syndrome, thrombocytopenia

23
New cards

common adverse effect of the tetracyclines

photosensitivity

24
New cards

DDI with the tetracyclines

oral cations

25
New cards

do doxycline or omadacycline need renal dose adjustment?

no

26
New cards

adverse effects of the oxazolidinones

myelosuppression, peripheral neuropathy, serotonin syndrome, thrombocytopenia

27
New cards

do the oxazolidinones need renal dose adjustment?

no

28
New cards

DDI of the oxazolidinones

serotonergic agents

29
New cards

adverse effect of dalbavancin and oritavancin

infusion reaction

30
New cards

DDI of oritavancin

warfarin, heparin, coagulation tests

31
New cards

adverse effect of telavancin

foamy urine, nephrotoxicity, infusion-related reaction, taste disturbance,

32
New cards

DDI of telavancin

heparin, coagulation tests

33
New cards

adverse effect of vancomycin

nephrotoxicity, infusion-related reaction

34
New cards

DDI of vancomycin

nephrotoxic agents

35
New cards

adverse effects of fluoroquinolones

CNS effects, peripheral neuropathy, photosensitivity, QT prolongation, tendinitis, tendon rupture

36
New cards

DDI of fluoroquinolones

oral cations

37
New cards

which fluoroquinolone does not have an adverse effect of QT prolongation or photosensitivity?

delafloxacin

38
New cards

does moxifloxacin need renal dose adjustment?

no

39
New cards

adverse effect of clindamycin

C.diff diarrhea

40
New cards

does clindamycin need renal dose adjustment?

no

41
New cards

adverse effect of daptomycin

increased creatinine phosphokinase, eosinophilic pneumonia

42
New cards

does daptomycin need higher or lower doses for more severe infections (bacteremia, osteomyelitis, vancomycin-resistant)?

higher

43
New cards

DDI of daptomycin

statins

44
New cards

adverse effect of metronidazole

metallic taste, peripheral neuropathy

45
New cards

what should you avoid taking metronidazole with?

alcohol

46
New cards

DDI of metronidazole

warfarin

47
New cards

adverse effect of mupirocin

skin irritation

48
New cards

adverse effects of trimethoprim-sulfamethoxazole

bone marrow suppression, increased potassium, increased serum creatinine

49
New cards

should you use higher or lower doses of trimethoprim-sulfamethoxazole for diabetic foot infections?

higher

50
New cards

DDI for trimethoprim-sulfamethoxazole

warfarin, renin-angiotensin-aldosterone system inhibitors

51
New cards

which organism should be empirically treated for with the presence of purulence in the setting of an SSTI?

MRSA

52
New cards

which organisms should be empirically treated for with the absence of purulence in the setting of an SSTI?

MSSA, Streptococcus spp., and gram negative bacilli

53
New cards

when can NO antibiotics potentially be a treatment option for SSTIs?

in mild purulent infections

54
New cards

when are oral antibiotics for SSTI treatment recommended?

SSTI

mild non-purulent infections

moderate purulent infections

diabetic foot infections

mild diabetic foot infections

moderate diabetic foot infections

severe diabetic foot infections

55
New cards

when are intravenous antibiotics for SSTI treatment

recommended?

SSTI

moderate non-purulent infections

severe purulent and non-purulent infections

diabetic foot infections

moderate diabetic foot infections

severe diabetic foot infections

56
New cards

which antibiotics commonly used for the treatment of SSTIs come in an oral formulation?

amoxicillin-clavulanate

dicloxacillin

penicillin VK

cefuroxime

cephalexin

doxycyline

minocycline

omadacycline

linezolid

tedizolid

ciprofloxacin

delafloxacin

levofloxacin

moxifloxacin

clindamycin

metronidazole

trimethoprim-sulfamethoxazole

57
New cards

which antibiotics commonly used for the treatment of SSTIs come in an intravenous formulation?

ampicillin-sulbactam

nafcillin

oxacillin

penicillin VK

penicillin G

piperacillin-tazobactam

cefazolin

cefepime

cefoxitin

ceftraoline

ceftazidime

ceftriaxone

doripenem

ertapenem

imipenem-cilastatin

meropenem

doxycyline

minocycline

omadacycline

linezolid

tedizolid

oritavancin

telavancin

vancomycin

ciprofloxacin

delafloxacin

levofloxacin

moxifloxacin

aztreonam

clindamycin

daptomycin

metronidazole

trimethoprim/sulfamethoxazole

58
New cards

which antibiotics commonly used for the treatment of SSTIs cover MRSA?

clindamycin PO

doxycycline

TMP-SMX

ceftraoline

dalbavancin

daptomycin

linezolid

oritavancin

tedizolid

vancomycin

59
New cards

which antibiotics commonly used for the treatment of SSTIs cover Pseudomonas?

aztreonam

carbapenem

cefepime

ciprofloxacin

levofloxacin

piperacillin-tazobactam

60
New cards

which antibiotics commonly used for the treatment of SSTIs cover anaerobes?

ampicillin-sulbactam

clindamycin

piperacillin-tazobactam

metronidazole

61
New cards

what is the place in therapy of dalbavancin, oritavancin?

one time infusion

62
New cards

what is the place in therapy of delafloxacin?

-broad coverage (MRSA, P. aeruginosa)

-no known QT prolongation or phototoxicity

63
New cards

what is the place in therapy of omadacycline?

activity against tetracycline-resistant pathogens

64
New cards

what is the place in therapy of tedizolid?

-less frequent dosing

-less risk of serotonin syndome

-less potential for thrombocytopenia compared with linezolid

65
New cards

when would a patient be "eligible" to switch from an intravenous antibiotic to an oral antibiotic?

-intravenous antibiotics > 24 hours

-stable infection

-clinical improvement

-afebrile

-WBC trending down

-hemodynamically stable

-ability to tolerate oral

-bacteria susceptibility to oral treatment

66
New cards

how long should a SSTI typically be treated?

SSTI

individualized to patient response, but typically 5 to 14 days

diabetic foot infection

1 to 4 weeks

67
New cards

organism that causes streaking, nonpurulent cellulitis

streptococcus spp.

68
New cards

organism that causes purulence and erythema

staphylococcus spp.

69
New cards

organism that causes pain out of proportion to exam

necrotizing facitis

70
New cards

comorbidities of SSTIs

-diabetes

-peripheral artery disease

-poor nutritional status

-concomitant osteomyelitis

71
New cards

treatment for mild purulent SSTIs

empiric MRSA coverage

no antibiotics

72
New cards

treatment for moderate purulent SSTIs

empiric MRSA coverage

clindamycin PO

doxycycline

tmp-smx

73
New cards

treatment for severe purulent SSTIs

empiric MRSA coverage

ceftraoline

dalbavancin

daptomycin

linezolid

oritavancin

tedizolid

vanocmycin

74
New cards

treatment for mild non-purulent SSTIs with no MRSA risk factors (empiric MSSA, sttreptococcus spp., empiric GMB coverage)

cephalexin

clindamycin PO

dicloxacillin

penicillin VK

75
New cards

treatment for moderate non-purulent SSTIs with no MRSA risk factors (empiric MSSA, sttreptococcus spp., empiric GMB coverage)

cefazolin

ceftriaxone

clindamycin IV

penicillin

76
New cards

treatment for severe non-purulent SSTIs with no MRSA risk factors (empiric MSSA, sttreptococcus spp., empiric GMB coverage)

vancomycin AND piperacillin-tazobactam

imipenem-cilastatin

meropenem

77
New cards

treatment for mild non-purulent SSTIs with MRSA risk factors (empiric MSSA, sttreptococcus spp., empiric GMB coverage)

doxycycline

tmp-smx

AND

penicillin

amoxicillin

cephalexin

78
New cards

treatment for moderate non-purulent SSTIs with MRSA risk factors (empiric MSSA, sttreptococcus spp., empiric GMB coverage)

ceftraoline

dalbavancin

daptomycin

linezolid

oritavancin

tedizolid

vancomycin

79
New cards

treatment for severe non-purulent SSTIs with MRSA risk factors (empiric MSSA, sttreptococcus spp., empiric GMB coverage)

vancomycin

AND

piperacillin-tazobactam

imipenem-cilastatin

meropenem

80
New cards

treatment for mild foot infections based on Staphylococcus spp., Streptococcus infections

amoxicillin-clavulanate

cephalexin

clindamycin

dicloxacillin

levofloxacin

moxifloxacin

81
New cards

treatment for moderate/severe diabetic foot infections based on susceptible MSSA, Streptococcus spp., and Enterobacteriaceae infections

ampicillin-sulbactam

cefoxitin

ertapenem

imipenem-cilastatin

levofloxacin

moxifloxacin

82
New cards

treatment for moderate/severe diabetic foot infections based on susceptible MRSA infections

daptomycin

linezolid

vancomycin

83
New cards

treatment for moderate/severe diabetic foot infections based on anaerobes infections

ampicillin-sulbactam

clindamycin

piperacillin-tazobactam

metronidazole

84
New cards

treatment for moderate/severe diabetic foot infections based on Pseudomonas infections

aztreonam

carbapenem

cefepime

ciprofloxacin

levofloxacin

piperacillin-tazobactam

85
New cards

treatment for human or animal bites via *empiric Staphylococcus spp.; Streptococcus spp.; Pasteurella multocida (cat or dog bites); Eikenella corrodens (human bites); anaerobic coverage"

amoxicillin-clavulante

doxycycline

moxifloxacin

86
New cards

when do incision and drainage function need antibiotic therapy?

if:

-inability to drain completely

-lack of response

-associated septic phlebitis

-severe or extensive disease

-systemic illness

-extremes of age

-associated comorbidities or immunosuppression